Inventor · disambiguated record
Zili An
Also filed as: AN ZILI
15 granted patents·8 pending applications·96 citations·filing 2010–2023
93Inventor score
Top patents by PatentIndex Score
23 records- 0197US11559582B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2020·Granted Jan 24, 2023·3 cites·32 claims
- 0295USRE47103EAntibody drug conjugates (ADC) that bind to 158P1D7 proteinsAGENSYS INC·Filed 2017·Granted Oct 30, 2018·7 cites·67 claims
- 0394US8309093B2Antibody drug conjugates (ADC) that bind to 24P4C12 proteinsGUDAS JEAN·Filed 2010·Granted Nov 13, 2012·19 cites·15 claims
- 0493US10894090B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2018·Granted Jan 19, 2021·4 cites·38 claims
- 0593US9314538B2Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2015·Granted Apr 19, 2016·9 cites·33 claims
- 0693US8968742B2Antibody drug conjugates (ADC) that bind to 158P1D7 proteinsAGENSYS INC·Filed 2013·Granted Mar 3, 2015·7 cites·32 claims
- 0792US9078931B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2013·Granted Jul 14, 2015·11 cites·8 claims
- 0891US9962454B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2016·Granted May 8, 2018·6 cites·5 claims
- 0991US9926376B2Antibody drug conjugates (ADC) that bind to 158P1D7 proteinsAGENSYS INC·Filed 2016·Granted Mar 27, 2018·4 cites·24 claims
- 1090US10669348B2Antibody drug conjugates (ADC) that bind to 158P1D7 proteinsAGENSYS INC·Filed 2018·Granted Jun 2, 2020·2 cites·30 claims
- 1190US8637642B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsSATPAYEV DAULET·Filed 2011·Granted Jan 28, 2014·12 cites·15 claims
- 1289USRE48389EAntibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2017·Granted Jan 12, 2021·2 cites·110 claims
- 1386US2023346968A1Antibody drug conjugates (adc) that bind to 191p4d12 proteinsAGENSYS INC·Filed 2022·Application pending·0 cites
- 1485US2024043556A1Antibody drug conjugates (adc) that bind to 158p1d7 proteinsAGENSYS INC·Filed 2023·Application pending·0 cites
- 1583US9308278B2Antibody drug conjugates (ADC) that bind to 161P2F10B proteinsAGENSYS INC·Filed 2013·Granted Apr 12, 2016·4 cites·14 claims
- 1682US8609092B2Antibody drug conjugates (ADC) that bind to 161P2F10B proteinsTORGOV MICHAEL·Filed 2011·Granted Dec 17, 2013·6 cites·5 claims
- 1774US11634503B2Antibody drug conjugates (ADC) that bind to 158P1D7 proteinsAGENSYS INC·Filed 2020·Granted Apr 25, 2023·0 cites·23 claims
- 1862US2019328898A1Antibody drug conjugates (adc) that bind to 161p2f10b proteinsAGENSYS INC·Filed 2018·Application pending·0 cites
- 1961US2015238633A1Antibody drug conjugates (adc) that bind to 158p1d7 proteinsAGENSYS INC·Filed 2015·Application pending·0 cites
- 2057US2013136756A1Antibody drug conjugates (adc) that bind to 24p4c12 proteinsAGENSYS INC·Filed 2012·Application pending·0 cites
- 2155US2016256563A1Antibody drug conjugates (adc) that bind to 161p2f10b proteinsAGENSYS INC·Filed 2016·Application pending·0 cites
- 2250US2021388100A1Compositions and methods regarding engineered and non-engineered gamma delta t-cells for treatment of hematological tumorsADICET BIO INC·Filed 2019·Application pending·0 cites
- 2350US2021388109A1Compositions and methods regarding engineered and non-engineered gamma delta t-cells for treatment of solid tumorsADICET BIO INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zili An files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →